Don’t tell Ted Driscoll now’s a bad time to be a healthcare investor.
Despite frequent industry complaints of an overly burdesome regulatory environment and a soft IPO market, the Claremont Creek Ventures partner says technology and demographics have combined to create favorable circumstances for healthcare investors.
A digital imaging expert with a PhD from Stanford University to prove it, Driscoll holds 40 imaging-related U.S. and foreign patents and has helped found five imaging companies.
Claremont Creek’s healthcare portfolio includes wound closure technology company Zipline Medical, “bionic leg” company Tibion and genomic technology company GigaGen.
To read the full, original article click on this link: Why one VC thinks now’s a great time to be a healthcare investor
